AI assistant
Sending…
Cabaletta Bio, Inc. — Director's Dealing 2021
Sep 3, 2021
33628_dirs_2021-09-03_85fa3a02-1daf-46bf-9bc5-b7e5c39d7d57.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2021-09-01
Reporting Person: Gerard Michael (General Counsel)
More from Cabaletta Bio, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 11
Regulatory Filings
2026
Jun 3
Proxy Solicitation & Information Statement
2026
Jun 1
Interim / Quarterly Report
2026
May 14
Earnings Release
2026
May 14
Regulatory Filings
2026
May 14
Capital/Financing Update
2026
May 4
Capital/Financing Update
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28